La licence obligatoire : outil emblématique de la protection de la santé publique au Sud

Is compulsory licensing good for public health in the South? This paper proposes a survey of the literature examining the link between this flexibility provided by the TRIPS Agreement, which authorizes the suspension of a monopoly related to a patent and the local production of generics, and drug ac...

Full description

Saved in:
Bibliographic Details
Main Author: Samira Guennif
Format: Article
Language:English
Published: Association Recherche & Régulation 2015-06-01
Series:Revue de la Régulation
Subjects:
Online Access:https://journals.openedition.org/regulation/11248
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832577872277012480
author Samira Guennif
author_facet Samira Guennif
author_sort Samira Guennif
collection DOAJ
description Is compulsory licensing good for public health in the South? This paper proposes a survey of the literature examining the link between this flexibility provided by the TRIPS Agreement, which authorizes the suspension of a monopoly related to a patent and the local production of generics, and drug accessibility in developing countries. On the basis of a conceptual framework specifying the three dimensions of accessibility, this survey will systematically compare the theoretical arguments and empirical evidence by discussing successively the impact of compulsory licensing on affordability, availability and quality of HIV/AIDS drugs in the South. Thus, it appears that the debate is unresolved regarding the utility of compulsory licensing in the promotion of public health while its use is indeed rare and complicated in developing countries.
format Article
id doaj-art-131a01c4a44e4cd59739e3bfc731b9cd
institution Kabale University
issn 1957-7796
language English
publishDate 2015-06-01
publisher Association Recherche & Régulation
record_format Article
series Revue de la Régulation
spelling doaj-art-131a01c4a44e4cd59739e3bfc731b9cd2025-01-30T14:27:11ZengAssociation Recherche & RégulationRevue de la Régulation1957-77962015-06-011710.4000/regulation.11248La licence obligatoire : outil emblématique de la protection de la santé publique au SudSamira GuennifIs compulsory licensing good for public health in the South? This paper proposes a survey of the literature examining the link between this flexibility provided by the TRIPS Agreement, which authorizes the suspension of a monopoly related to a patent and the local production of generics, and drug accessibility in developing countries. On the basis of a conceptual framework specifying the three dimensions of accessibility, this survey will systematically compare the theoretical arguments and empirical evidence by discussing successively the impact of compulsory licensing on affordability, availability and quality of HIV/AIDS drugs in the South. Thus, it appears that the debate is unresolved regarding the utility of compulsory licensing in the promotion of public health while its use is indeed rare and complicated in developing countries.https://journals.openedition.org/regulation/11248southern countriespublic healthpatentessential drugs accessibilitycompulsory licenseHIV/AIDS
spellingShingle Samira Guennif
La licence obligatoire : outil emblématique de la protection de la santé publique au Sud
Revue de la Régulation
southern countries
public health
patent
essential drugs accessibility
compulsory license
HIV/AIDS
title La licence obligatoire : outil emblématique de la protection de la santé publique au Sud
title_full La licence obligatoire : outil emblématique de la protection de la santé publique au Sud
title_fullStr La licence obligatoire : outil emblématique de la protection de la santé publique au Sud
title_full_unstemmed La licence obligatoire : outil emblématique de la protection de la santé publique au Sud
title_short La licence obligatoire : outil emblématique de la protection de la santé publique au Sud
title_sort la licence obligatoire outil emblematique de la protection de la sante publique au sud
topic southern countries
public health
patent
essential drugs accessibility
compulsory license
HIV/AIDS
url https://journals.openedition.org/regulation/11248
work_keys_str_mv AT samiraguennif lalicenceobligatoireoutilemblematiquedelaprotectiondelasantepubliqueausud